Genomics: Unlocking the Blueprint of Life
Our Genomics division is at the forefront of exploring the intricate complexities of DNA, RNA, and their interactions. We leverage cutting-edge sequencing technologies, advanced bioinformatics, and sophisticated analytical tools to unravel the genetic basis of diseases, understand evolutionary processes, and develop novel therapeutic strategies.
Key Research Projects
Personalized Cancer Genomics
Analyzing tumor genomes to identify actionable mutations and predict patient response to targeted therapies. Our work aims to revolutionize cancer treatment through precision medicine.
CRISPR-Cas9 Gene Editing
Developing and optimizing CRISPR-based technologies for precise gene editing to correct genetic defects responsible for inherited diseases. We are exploring applications for cystic fibrosis and sickle cell anemia.
Metagenomics and Microbiome Analysis
Investigating the genetic material of microbial communities to understand their role in human health, disease, and environmental interactions. Focus on gut microbiome and its impact on metabolic disorders.
Epigenomics and Gene Regulation
Studying epigenetic modifications (like DNA methylation and histone modifications) that control gene expression without altering the DNA sequence itself. Crucial for understanding development and disease.
Our Technology Stack
We utilize state-of-the-art technologies including Illumina NovaSeq, Oxford Nanopore sequencing, PacBio HiFi sequencing, and a robust high-performance computing cluster for data analysis. Our bioinformatics pipeline includes tools like GATK, STAR, Salmon, and custom Python/R scripts.
Learn More About Our Tech